King Saud University Repository >
King Saud University >
King Saud University Initial Collection >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/2598

Title: Mycophenolate Mofetil (CellCept) in Patients with Autoimmune Hepatitis
Authors: Abdo, Ayman A.
Keywords: Mycophenolate
Issue Date: Jan-2006
Publisher: King Saud University
Citation: The Saudi Journal of Gastroenterology: 12 (1); 38
Abstract: Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver of unknown cause. Typically, immune suppressive therapy is used initially for treatment, either in the form of steroids or Azathioprime. In a small proportion of patients, steroids resistance or steroid intolerance develops. When patients are unresponsive to steroids, or develop severe significant side effects to their use, alternative treatments must be used. Mycophenolate mofetil (Cellcept) is a potent immune suppressive medication that is used in a wide variety of autoimmune diseases as well as post solid organ transplantation. Data is emerging to suggest that this medication may be used in selected patients with steroid resistance or steroid intolerance. This data is summarized in this review.
URI: http://hdl.handle.net/123456789/2598
Appears in Collections:King Saud University Initial Collection

Files in This Item:

File Description SizeFormat
Mycophenolate mofetil (CellCept) in patients with autoimmune hepatitis.pdf191 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


DSpace Software Copyright © 2002-2009 MIT and Hewlett-Packard - Feedback